Our Pricing

What To Do If You Forgot To Refrigerate Your Wegovy

Published on: June 03, 2026

If you forgot to refrigerate Wegovy UK pens overnight or during travel, don't panic—understanding the medication's temperature stability is crucial before deciding whether your pen remains safe to use. Wegovy (semaglutide) has specific storage tolerances that allow temporary room temperature exposure, but exceeding these limits can compromise the medication's effectiveness and safety.

How Long Can Wegovy Stay Out of the Fridge?

Unopened Wegovy pens can remain at room temperature (up to 30°C) for up to 28 days without compromising the medication's stability [1]. This built-in tolerance accounts for typical scenarios like postal delays, travel, or accidental overnight storage at room temperature. Once you've opened and used a Wegovy pen, it can stay out of refrigeration for the same 28-day period, provided temperatures don't exceed 30°C.

If your pen has been left out for less than 28 days and hasn't been exposed to direct sunlight or temperatures above 30°C, it's generally safe to continue using after returning it to the fridge. However, if you're unsure about the exact duration or temperature conditions, contact our clinical team at Cured Pharmacy on (+44) 116 4646009 for personalised guidance. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our UK-registered prescribers can assess your specific situation and advise whether a replacement pen is necessary.

Signs Your Wegovy Pen May Be Compromised

Temperature abuse doesn't always produce visible changes immediately. Semaglutide's molecular structure can degrade at elevated temperatures even when the solution still appears clear [1]. This is why adherence to the 28-day room temperature limit and 30°C maximum is critical—exceeding these parameters may reduce the medication's glucose-lowering and weight-loss efficacy without obvious visual cues.

If you've accidentally frozen Wegovy (temperatures below 2°C), the pen must be discarded immediately, even if it later thaws and appears normal. Freezing irreversibly damages semaglutide's protein structure, rendering it ineffective and potentially unsafe [2].

Visual Inspection Checklist

Before using a Wegovy pen that's been left unrefrigerated, inspect the solution carefully through the pen window. Semaglutide should appear clear and colourless—any cloudiness, discolouration, particles, or crystallisation indicates the medication has degraded and should not be used [2]. Even if the pen was only out of the fridge briefly, these visual changes mean the active ingredient has become unstable.

Additionally, check the pen's physical integrity. If the pen was exposed to temperatures above 30°C (such as in a hot car or near a radiator), the plastic components may have warped slightly, and internal seals could be compromised. When in doubt, err on the side of caution and request a replacement through your prescriber rather than risk injecting degraded medication.

Proper Wegovy Storage Guidelines UK

Store unopened Wegovy pens in a refrigerator at 2°C to 8°C, ideally in the original carton to protect from light. Never store pens in the freezer compartment or directly against the back wall of the fridge where temperatures may drop below 2°C. Many patients find storing Wegovy on a middle shelf or in the door compartment (if temperatures remain stable) prevents accidental freezing.

Once you've used a Wegovy pen for the first time, you can choose to keep it refrigerated or store it at room temperature (below 30°C) for up to 28 days. Many patients prefer room temperature storage for in-use pens, as this reduces injection-site discomfort—cold injections can cause temporary stinging. Always replace the pen cap after each use to protect the medication from light and contamination.

When travelling with Wegovy, use an insulated medication pouch with a temperature monitor if you'll be away from refrigeration for extended periods. Avoid leaving pens in checked luggage (where temperatures can drop below freezing at altitude) or in vehicles during warm weather. If you're travelling internationally, carry your prescription documentation and consider requesting a letter from your prescriber confirming your need for refrigerated medication.

What Happens If You Use Improperly Stored Wegovy

If you suspect you've been using improperly stored Wegovy and have noticed diminished effects, contact your prescriber rather than increasing your dose independently. Your healthcare provider may recommend continuing with a fresh pen at your current dose level or adjusting your treatment plan based on your recent glucose readings and weight loss trajectory.

Reduced Efficacy vs Safety Concerns

Using Wegovy that's been stored incorrectly primarily risks reduced therapeutic effect rather than immediate harm. Degraded semaglutide may not adequately suppress appetite or regulate blood glucose, potentially stalling your weight loss progress or causing glucose fluctuations if you're using the medication for type 2 diabetes management [3]. You might notice increased hunger, less satiety after meals, or slower weight loss compared to previous weeks.

While improperly stored semaglutide is unlikely to cause acute toxicity, using degraded medication introduces unnecessary uncertainty into your treatment plan. The STEP clinical trials that demonstrated semaglutide's average 15% body weight reduction over 68 weeks relied on properly stored, stable medication [3]. Using compromised pens means you're not receiving the evidence-based treatment that regulatory bodies like the MHRA licensed based on those trial results.

Forgot to Refrigerate Wegovy: Immediate Steps

If you discover your Wegovy pen has been left out, immediately note the time it's been unrefrigerated and the ambient temperature conditions. Place the pen back in the fridge (not the freezer) and mark the date on the pen label. Calculate whether the total room temperature exposure exceeds 28 days—if not, and temperatures stayed below 30°C, the pen should remain effective.

Perform a visual inspection as described earlier: hold the pen up to light and check for clarity. If the solution appears normal and you're within the 28-day window, you can continue your dosing schedule as planned. However, if you're approaching your next dose and have any doubts about the pen's integrity, it's safer to delay injection and consult a healthcare professional first.

Document the incident for your records, especially if you notice any changes in the medication's effectiveness over subsequent doses. This information helps your prescriber assess whether the storage lapse affected your treatment outcomes. At Cured Pharmacy, our clinical team can review your situation during a brief consultation and arrange a replacement pen if necessary, ensuring continuity of your weight loss programme.

Wegovy Storage vs Other Weight Loss Injections

All GLP-1 medications share the same fundamental vulnerability: they're protein-based molecules that degrade when exposed to temperature extremes or prolonged heat. Whether you're using Wegovy, Saxenda, or Mounjaro, establishing a consistent storage routine—checking fridge temperatures monthly, using insulated travel cases, and setting phone reminders to return pens to refrigeration—protects your investment in these prescription treatments and ensures you receive their full clinical benefit.

Comparing Semaglutide and Tirzepatide Stability

Different GLP-1 receptor agonists have varying storage requirements. Saxenda (liraglutide), which requires daily injections, can stay at room temperature for 30 days after first use—similar to Wegovy's 28-day window [4]. However, Saxenda's daily dosing means patients go through pens faster, reducing the cumulative risk of prolonged room temperature exposure.

Mounjaro (tirzepatide), available from £79.00 at Cured Pharmacy, follows comparable storage guidelines: refrigerate at 2°C to 8°C, with up to 21 days allowed at room temperature (below 30°C) for in-use pens [4]. Tirzepatide's dual GIP/GLP-1 mechanism produces greater average weight loss in clinical trials compared to semaglutide alone, but both medications require the same careful attention to storage conditions to maintain their molecular stability.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2022). Semaglutide (Wegovy): Storage and handling guidance for healthcare professionals. GOV.UK. https://www.gov.uk/drug-safety-update/semaglutide-wegovy-storage-and-handling [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.